Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T14:46:38.688Z.
Calculation as of: 2026-10-06T14:46:38.688Z.
Quote observation: 2026-10-06T14:45:13.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: b1e589d4888711efc6e495fe73fbc3b606428562d81b06b8c422d1cee3adbcc2
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Establishment Labs Holdings Inc.
Market Cap
$1.94B
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.99B
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.89B
Free Cash Flow Yield
N/A
TTM Avg
0.78%
3Y Avg
0.67%
5Y Avg
0.58%
Market Cap
$2.00B
Free Cash Flow Yield
8.68%
TTM Avg
6.70%
3Y Avg
5.44%
5Y Avg
5.44%
Market Cap
$2.00B
Free Cash Flow Yield
5.85%
TTM Avg
5.28%
3Y Avg
2.56%
5Y Avg
2.10%
Market Cap
$2.01B
Free Cash Flow Yield
17.79%
TTM Avg
9.91%
3Y Avg
8.62%
5Y Avg
8.62%
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Establishment Labs Holdings Inc. (ESTA) | $1.94B | N/A | N/A | N/A | N/A |
| Immunome, Inc. (IMNM)vs › | $1.93B | N/A | 2.45% | 2.45% | 2.45% |
| AxoGen, Inc. (AXGN)vs › | $1.97B | 0.13% | 0.28% | 0.23% | 0.23% |
| Azenta, Inc. (AZTA)vs › | $1.90B | 0.52% | 2.40% | 1.84% | 1.74% |
| Mineralys Therapeutics, Inc. (MLYS)vs › | $1.99B | N/A | N/A | N/A | N/A |
| BioLife Solutions, Inc. (BLFS)vs › | $1.89B | N/A | 0.78% | 0.67% | 0.58% |
| Aurinia Pharmaceuticals Inc. (AUPH)vs › | $2.00B | 8.68% | 6.70% | 5.44% | 5.44% |
| Inspire Medical Systems, Inc. (INSP)vs › | $2.00B | 5.85% | 5.28% | 2.56% | 2.10% |
| BioCryst Pharmaceuticals, Inc. (BCRX)vs › | $2.01B | 17.79% | 9.91% | 8.62% | 8.62% |
| Agios Pharmaceuticals, Inc. (AGIO)vs › | $1.86B | N/A | 2.77% | 2.77% | 2.77% |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
